Tag: reconsideration

news-12102024-071512

FDA Reconsiders Removing Eli Lilly Weight Loss Drug from Shortage List

The Food and Drug Administration, or FDA, announced on Friday that it would be revisiting its decision to remove Eli Lilly's tirzepatide, which is known as Mounjaro for diabetes and Zepbound for obesity, from...